AMG-706 inhibitor – It is an orally administered small molecule belonging to angiokinase inhibitor class which acts as an antagonist of VEGF receptors, platelet-derived growth factor receptors, and stem cell factor receptors.
Description
AMG 706 is an experimental drug candidate originally developed by Amgen
Server
cloudflare
DNS
View domain name system records, including the A, AAAA, MX and NS records.